D61.1

Drug-induced aplastic anemia

Billable / specific

D61.1 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Excludes2

Not included here — may be reported together when both conditions exist.

  • autoimmune disease (systemic) NOS (M35.9) (from D61)
  • certain conditions originating in the perinatal period (P00-P96) (from D61)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A) (from D61)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from D61)
  • endocrine, nutritional and metabolic diseases (E00-E88) (from D61)
  • human immunodeficiency virus [HIV] disease (B20) (from D61)
  • injury, poisoning and certain other consequences of external causes (S00-T88) (from D61)
  • neoplasms (C00-D49) (from D61)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from D61)
  • neutropenia (D70.-) (from D61)

Use additional code

Add a code to identify the following, if applicable.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Also known as

  • Anemia, aplastic, drug-induced
  • Anemia, aplastic, due to drugs

Parent code

  • D61Other aplastic anemias and other bone marrow failure syndromesHeader

Related codes

  • D61.0Constitutional aplastic anemiaHeader
  • D61.2Aplastic anemia due to other external agentsBillable
  • D61.3Idiopathic aplastic anemiaBillable
  • D61.8Other specified aplastic anemias and other bone marrow failure syndromesHeader
  • D61.9Aplastic anemia, unspecifiedBillable

Browse